Lynx1 Capital Management as of March 31, 2024
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 15 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences | 23.2 | $89M | 2.3M | 39.64 | |
| Merus N V (MRUS) | 17.6 | $68M | 1.5M | 45.03 | |
| Stoke Therapeutics (STOK) | 12.9 | $50M | 3.7M | 13.50 | |
| Tscan Therapeutics (TCRX) | 10.8 | $42M | 5.2M | 7.94 | |
| Cabaletta Bio (CABA) | 9.2 | $36M | 2.1M | 17.06 | |
| Gh Research Ordinary Shares (GHRS) | 9.1 | $35M | 3.3M | 10.66 | |
| C4 Therapeutics Com Stk (CCCC) | 7.7 | $30M | 3.6M | 8.17 | |
| Silence Therapeutics Ads (SLN) | 2.9 | $11M | 527k | 21.60 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.3 | $8.9M | 1.4M | 6.38 | |
| Passage Bio | 1.7 | $6.5M | 4.8M | 1.35 | |
| Kinnate Biopharma | 1.4 | $5.3M | 2.0M | 2.66 | |
| Nektar Therapeutics | 0.5 | $1.9M | 2.1M | 0.93 | |
| Pieris Pharmaceuticals | 0.4 | $1.6M | 8.8M | 0.18 | |
| Bionomics Ads | 0.2 | $839k | 815k | 1.03 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $197k | 17k | 11.30 |
